SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patien...
Q1 2026
May 11, 2026
FY 2025
Mar 4, 2026
Q4 2025
Q3 2025
Nov 5, 2025
Q2 2025
Aug 13, 2025